EN | RU
EN | RU

Help Support

Back

Relative absorption of gastroresistant risedronate taken with food or fasted vs immediate-release

Gastroresistant Risedronate Gastroresistant Risedronate
Gastroresistant Risedronate Gastroresistant Risedronate

Osteoporosis people often consume oral bisphosphonates with food that renders these medications inefficient. An open-label randomized study was carried out to compare the relative absorption of 4 formulations of gastro-resistant 35 mg risedronate versus 35 mg immediate-release risedronate taken fasted.

See All

Key take away

All the gastro-resistant 35 mg risedronate formulations were safe and well-tolerated under fasted and fed conditions, without any severe side effects.

Background

Osteoporosis people often consume oral bisphosphonates with food that renders these medications inefficient. An open-label randomized study was carried out to compare the relative absorption of 4 formulations of gastro-resistant 35 mg risedronate versus 35 mg immediate-release risedronate taken fasted.

Method

In this study, the relative absorption of gastro-resistant formulations administered fasted and fed was compared along with the assessment of the disintegration site. A total of 160 healthy subjects were randomly divided into 1 of 9 intervention groups. In group A, immediate-release risedronate was taken fasted and in group B-I, formulations 1-4 were taken fasted or fed. The fasted group fasted for eight hours before the dose and four hours after the dose.

The Fed groups fasted for seven and a half hours and then received risedronate with breakfast. Urine collection was done until 72 hours after the dose and was assessed utilizing liquid chromatography. To evaluate tablet disintegration, around 7 subjects underwent scintigraphic monitoring from each group.

Result

For group A, the percentage of the total dose recovered in urine (A'e) was ~0.5%. In this study, the A'e of formulations 1-4 administered fasted was found to be 0.220%, 0.298%, 0.154%, and 0.108% respectively. Compared with the A'e of formulations 2 (-73%), 3 (-80%), and 4 (-65%), the A'e of formulation 1 with food reduced least versus fasted (-27%). Formulation 4 disintegrated closer to the large intestine and 1-3 disintegrated in the small intestine.

Conclusion

All the gastro-resistant formulations showed good tolerability with the known safety profile for immediate-release risedronate. When taken fasted, formulation 2 had the greatest absorption.  Formulation 1 absorption was minimally influenced by food.

Source:

Pharmacology Research & Perspectives

Article:

An open-label randomized study of the relative absorption of gastro-resistant risedronate taken fasted or with food versus immediate-release risedronate

Authors:

Diane Kleinermans et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru
Try: